All 50 states, D.C., and four U.S. territories signed off on the multi-billion dollar settlement proposal with OxyContin ...

A new drug is helping families who’ve spent years locking up or hiding food as their children with Prader-Willi syndrome deal ...

There's been a rise in patients booking facelifts, and more interest than ever in the cosmetic procedure. Here, experts ...

Hims and Hers stock rally looms with bullish EMAs, Novo Nordisk partnership, ZAVA acquisition, and new product launches ...

Interestingly, back in 2015, the death knell for the facelift was partly blamed on the rising popularity of non-invasive ...

Rebel Wilson has showed off the results of her latest health challenge. The 45-year-old actress has been on a weight loss ...

In many ways, it’s the renaissance no one saw coming. After all, a decade ago, the British Association of Aesthetic Plastic ...

A MUM-of-two who used to cancel nights out because she felt like “the fat one” has lost two stone in two months by using Mounjaro. Sarah Hill, 32, from Glasgow, is among the estimated 1.5 million ...

We have recently begun acquiring a new position in Novo Nordisk. Click here for our investment thesis on NVO stock.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

With many different species entering torpor for a variety of reasons, scientists are looking to their sleepy secrets for ways ...

An investigational drug developed by Eolo Pharma is showing promise in animal experiments and an early human trial. It could eventually be an alternative or add-on to popular GLP-1 medications.